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We have previously shown that peptide amide hydrogens undergo extensive intramolecular
migration (i.e., complete hydrogen scrambling) upon collisional activation of protonated
peptides (Jørgensen et al. J. Am. Chem. Soc. 2005, 127, 2785–2793). The occurrence of hydrogen
scrambling enforces severe limitations on the application of gas-phase fragmentation as a
convenient method to obtain information about the site-specific deuterium uptake for proteins
and peptides in solution. To investigate whether deprotonated peptides exhibit a lower level
of scrambling relative to their protonated counterparts, we have now measured the level of
hydrogen scrambling in a deprotonated, selectively labeled peptide using MALDI tandem
time-of-flight mass spectrometry. Our results conclusively show that hydrogen scrambling is
prevalent in the deprotonated peptide upon collisional activation. The amide hydrogens
(1H/2H) have migrated extensively in the anionic peptide, thereby erasing the original
regioselective deuteration pattern obtained in solution. (J Am Soc Mass Spectrom 2008, 19,
1719–1725) © 2008 American Society for Mass Spectrometry
The fragmentation behavior of protonated pep-tides upon collisional activation has been thefocus of many experimental and theoretical stud-
ies [1]. In comparison, deprotonated peptides have
received much less attention, and the mechanistic de-
tails of their fragmentation behavior are less well un-
derstood. We and others have previously investigated
the proton mobility in protonated peptides and proteins
upon collision-induced dissociation (CID) [2–12]. Our
studies were motivated by earlier reports claiming that
CID could be used to determine site-specific incorpora-
tion of deuterium in the backbone amides of peptides
that were deuterated in solution [13–16]. In these re-
ports, it was suggested that the level of intramolecular
migration of amide hydrogens (1H/2H) in the proton-
ated, collisionally activated peptide was negligible. It is
important to emphasize that negligible levels of hydro-
gen migration would dramatically improve the resolu-
tion of localizing deuterated sites by mass spectrometric
analysis of peptides and proteins labeled in solution
(1H/2H) exchange experiments. But recent results have
demonstrated unequivocally that all backbone amide
hydrogens are positionally randomized upon colli-
sional activation in the gaseous protonated peptide (i.e.,
causing 100% hydrogen scrambling) [3, 6, 7, 10]. This
implies that protonation of amide nitrogens is a revers-
ible process in the gaseous activated peptide, and that
the mobile proton (or deuteron) samples all exchange-
able sites before peptide bond cleavage. Interestingly,
this also occurs in singly protonated peptides exhibiting
a preferred site-selective cleavages at Asp residues,
which are thought to be induced by a reduced proton
mobility [6]. Deprotonated peptides are deficient in
protons and it is thus reasonable to assume that such
ions might exhibit a lower degree of hydrogen scram-
bling than their protonated counterparts. Furthermore,
low-energy CID of deprotonated peptides often yield a
fragment ion type (c-ion) that is observed only rarely in
protonated peptides [17]. The c-ion is the N-terminal
fragment ion that results from backbone N–C bond
cleavage. As anionic peptides thus exhibit different
fragmentation pathways (relative to their protonated
counterparts) and they have a proton deficit, we have
explored the extent of intramolecular migration of
amide hydrogens during collisional activation using a
unique model peptide with a receptor induced regios-
elective deuterium labeling [18].
A well-defined deuterium incorporation is the key
requirement for an accurate assessment of the level of
amide hydrogen scrambling during gas-phase activa-
tion. With our unique model peptide, the amides in the
N-terminal half are protiated, while the amides in its
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C-terminal half are deuterated as a consequence of a
high-affinity interaction with the urokinase receptor
[6, 7, 18]. If amide hydrogen scrambling occurs upon
gas-phase activation, the deuterons will inevitably mi-
grate towards the N-terminal half, while its amide
protons simultaneously migrate to the C-terminal half.
This positional randomization is readily detected as a
mass increase for the fragment ions of the N-terminal
half. The selective labeling of the intact peptide is conve-
niently accomplished in solution as the C-terminal half
harbors the high-affinity urokinase receptor-binding
sequence, whereas the N-terminal half comprise a non-
binding sequence that remains solvent exposed in the
complex. The receptor-binding sequence of the model
peptide adopts an -helical structure when it binds to
the hydrophobic ligand-binding cavity of the urokinase
receptor (Figure 1) [19]. The intramolecular hydrogen
bonds in the -helix protect the backbone amide hydro-
gens in the C-terminal half against isotopic exchange
with the solvent, while the N-terminal half is solvated
and thus undergoes rapid isotopic exchange (Figure 2).
The selective labeling of the peptide is carried out by
diluting fully deuterated peptide–receptor complex into a
protiated buffer. After a few seconds, the N-terminal
half is protiated, while the C-terminal half remains
deuterated due to its tight interaction with the receptor.
Upon lowering the pH and the temperature, the amide
hydrogen exchange reaction is quenched and the com-
plex dissociates, thereby liberating a selectively labeled
peptide for the following MS/MS experiments.
Experimental
Materials and Methods
D2O (99.9 atom % D) was obtained from Cambridge Iso-
tope Laboratories (Andover, MA). Ammonium acetate-d7
(98 atom % D) and the MALDI matrix: -cyano-4-
hydroxycinnamic acid (HCCA) were from Sigma-
Aldrich (St. Louis, MO). All other chemicals and
reagents were of the highest grade commercially avail-
able. The AE133 peptide (KGSGGD-Cha-FsrYLWS,
Cha is -cyclohexylalanine, lower case letters denote
d-chirality) was synthesized as reported previously
[20, 21]. Soluble, recombinant human urokinase-type
plasminogen activator receptor (uPAR) was pro-
duced in CHO-cells and immunoaffinity purified as
described previously [22].
Selective Labeling
Selectively labeled peptides were prepared as described
previously [6]. In brief, fully deuterated uPAR–peptide
complexes were prepared by mixing a 2-fold molar
excess of deuterated uPAR with deuterated peptide.
The selective labeling was achieved by a 50-fold dilu-
tion of deuterated uPAR–peptide complexes into proti-
ated buffer (i.e., exchange-out): 1 L of a 200 M
solution of the peptide ligand in the presence of 400 M
uPAR in deuterated buffer (50 mM d7-ammonium ace-
tate, pH 8.0, 0.10 M NaCl) was added to 49 L of the
corresponding protiated buffer (i.e., 50 mM ammonium
Figure 1. Crystal structure of the model peptide antagonist
in complex with uPAR. (a) The crystal structure solved for
uPAR in complex with the peptide antagonist AE147 (KSD-Cha-
FskYLWSSK) is shown using a surface representation for uPAR and
a stick representation for AE147. Intramolecular hydrogen bonding
of the main chain in AE147 is highlighted by yellow dashes. Note
the efficient burial of the peptide in the large hydrophobic
ligand-binding cavity in uPAR. (b) The core of the receptor-bound
peptide (D-Cha-FskYLWSS) is shown in a close-up as a stick
representation superimposed onto a semitransparent ribbon dia-
gram illustrating the right-handed 3.6 -helix of AE147 that is
stabilized upon binding to uPAR. Color coding according to atoms
is white (carbon), blue (nitrogen), red (oxygen), and orange
(sulfur). These molecular representations were created by PyMol
(DeLano Scientific), using the PDB coordinates 1YWH [19].
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acetate buffer, pH 8.0, 0.10 M NaCl). Solutions main-
tained at 0 °C were subjected to exchange for 30 s. The
1H/2H exchange solution was quenched by the addi-
tion of an equal volume of 0.5 M phosphate buffer (pH
2.2, 0 °C) and subjected immediately to rapid desalting.
Rapid Desalting and MALDI Sample Preparation
A chromatographic microcolumn (made in-house) was
used to desalt the selectively labeled peptide before
mass spectrometric analysis. The microcolumn was
prepared using Eppendorf GE Loader pipette tips
packed with a reversed-phase material for perfusion
chromatography (POROS R2; Applied Biosystems, Fra-
mingham, MA). The procedure for preparing microcol-
umns has been described previously [23]. To minimize
deuterium loss during desalting and MALDI sample
preparation, it was important to maintain low temper-
ature and low pH. A rack was designed to keep the tip
of the microcolumn, which contains the reversed-phase
material, submerged in ice-cold water during the entire
desalting procedure. The sample solution (10 L) was
mixed 1:1 (vol/vol) with ice-cold 0.1% trifluoroacetic
acid (TFA) and loaded onto the microcolumn. The
microcolumn was washed with 20 L ice-cold 0.1%
TFA. The peptides were eluted from the column using
0.5 L ice-cold HCCA in 70% acetonitrile/0.1% TFA (4
mg/mL) onto a cold MALDI plate, which was cooled
by placing it on a cold (20 °C) aluminum block.
Subsequently, the MALDI plate was immediately
loaded into the vacuum of the mass spectrometer and
allowed to dry to completeness inside the first vacuum
chamber (1  102 millibar).
MALDI-TOF and TOF/TOF Mass Spectrometry
Negative ion MALDI-TOF and MALDI-TOF/TOF mass
spectra were acquired on an Applied Biosystems (Fra-
mingham, MA) 4700 Proteomics Analyzer equipped
with a 200-Hz neodymium:yttrium-aluminum-garnet
laser operating at a wavelength of 355 nm. A prototype
version of this instrument has been described previ-
ously [24]. MALDI-TOF mass spectra were acquired in
reflectron mode with 470 ns delayed extraction, accu-
mulating 5000 laser shots; the acceleration voltage was
20 kV. For MS/MS experiments, the acceleration volt-
age was 8 kV, and the collision energy (ELAB) was 1 keV;
5000 laser shots were accumulated. Argon was used as
Figure 2. Regioselective deuterium labeling of peptide antago-
nist by protein stabilization of an -helix. The structural basis for
the selective shielding of main chain amide hydrogen atoms
located in the C-terminal half of the peptide AE133 (KGSGGD-
Cha-FsrYLWS) when bound to uPAR is shown schematically in
(a). This artistic representation is based on the structure of the
AE147–uPAR complex solved by X-ray crystallography (see Fig-
ure 1) by modifying the peptide sequence to represent AE133. The
shared core sequence forming the -helix is left unmodified
(except for the d-Lys¡d-Arg substitution) and the N-terminal
extension (KGSGG), which is added arbitrarily and located in the
solvent-exposed breach between uPAR domains I and III. In this
experimental setting, the main chain amide groups of AE133 are
deuterated in the complex as the peptide was incubated in 2H2O
before complex formation. Upon dilution into protiated solvent
the exposed amide groups of AE133 undergo rapid isotopic
exchange to incorporate protium [yellow sticks and asterisks in
(b)], whereas the amide groups that are engaged in formation of
the stable -helix remain deuterated for a significant time. This
regioselective deuterium labeling is retained after acid induced
complex dissociation and chromatographic purification due to an
efficient quenching of the chemical exchange rates for the amide
groups in the now unstructured and free peptide shown in (c). The
schematic representations were created by PyMol (DeLano Scien-
tific), using the PDB coordinates 1YWH [19] and modifying the
peptide sequence manually.
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a collision gas at an indicated manifold pressure of
1  106 millibar (note that the pressure is not
measured directly in the CID collision chamber).
Data Analysis
The data analysis was carried out as described previ-
ously [6]. Briefly, the average deuterium content was
determined by the difference in the average masses
between nonlabeled ions and the corresponding deu-
terated ions. The average masses were determined from
centroided isotopic distributions exported into a
spreadsheet using nominal masses. To calculate the
theoretical deuterium content for a fragment ion in case
of 100% scrambling, the experimental deuterium con-
tent of the precursor ion was divided by the number of
its exchangeable sites, and this ratio was then multi-
plied with the number of exchangeable sites in the
fragment ion. It is generally observed for protonated
peptides that the only exchangeable hydrogens are
those attached to heteroatoms [4, 9]. For deprotonated
peptides, however, some C-bonded hydrogens are also
mobilized during the activation process [25–27]. The
predominant backbone cleavage in the present study is
an N–C cleavage at an Asp residue. The proposed
mechanism for this cleavage involves deprotonation of
the C atom of Asp, thereby forming an enolate anion
[26]. Accordingly, we have categorized the two C-
bonded hydrogens as being exchangeable. It should be
noted, however, that this has only a minor effect on the
theoretical deuterium levels for 100% scrambling. Thus,
the theoretical value for the N-terminal fragment, c5-
CH2O, decreases by 7% when the C-bonded hydro-
gens are categorized as labile.
Results and Discussion
The CID fragmentation pattern of AE133 (KGSGGD-
Cha-FsrYLWS) in both positive and negative ion mode
is dominated by site-selective cleavages at the central
Asp6 residue. The major fragmentation pathway of
protonated AE133 is a cleavage of the Asp6-Cha7 amide
bond yielding the complementary fragment ion pair
b6/y8 (Figure 3a). Such a site-selective cleavage of an
amide bond C-terminal to an Asp residue is known to
occur when the number of protons is less than or equal
to the number of basic residues (Arg) [28, 29]. Depro-
tonated AE133 fragments predominantly by a backbone
cleavage of the N–C bond at Asp
6 yielding the com-
plementary fragment ion pair c5/z9 at m/z 402.2 and
1207.5 (theoretical values: m/z 402.2 and 1207.6) (Figure
3b). The c5 fragment undergoes further fragmentation
and CH2O is lost from the side chain of Ser to give the
abundant product ion c5-CH2O at m/z 372.2. Similarly,
the z9 ion dissociates further by elimination of H2O
yielding the most abundant fragment ion z9-H2O at m/z
1189.5. A subsequent loss of CH2O produces the frag-
ment ion z9-H2O-CH2O at m/z 1159.5. The identity of the
Figure 3. Collision-induced dissociation spectra of protonated and deprotonated AE133. (a) MALDI-
TOF MS/MS of protonated AE133, (b) deprotonated AE133, and (c) deprotonated acetylated AE133.
1722 BACHE ET AL. J Am Soc Mass Spectrom 2008, 19, 1719–1725
c5-CH2O and z9-H2O fragment ions were verified by
negative ion mode CID of N-terminal acetylated AE133
(Figure 3c). The results clearly show that c5-CH2O is a
N-terminal fragment and that z9-H2O is a C-terminal
fragment. The pronounced loss of H2O from the z9
fragment as well as the N–C bond cleavage at Asp
6
agree with the results of other investigators [30–32].
Similarly, the facile loss of CH2O from the side-chain of
Ser in both c5 and z9 is in agreement with results
obtained from dipeptides [33] and from larger peptides
[30, 34].
The c5-CH2O fragment ion at m/z 372.2 constitutes a
sensitive probe for the occurrence of amide hydrogen
scrambling. Before ion activation the residues within
this fragment contain 0 deuterons as they belong to
the nonbinding region of AE133. The onset of hydrogen
scrambling is readily detected by the mass increase that
inevitably results from migration of deuterium atoms
from the C-terminal half of AE133 to the N-terminal
half. Figure 4 shows the isotope distribution of the
c5-CH2O fragment obtained from CID of deprotonated
AE133 labeled with deuterium in the C-terminal half. It
is clear from this spectrum that hydrogen scrambling
has occurred as the isotopic envelope is mass shifted
relative to the isotopic natural abundance distribution.
The deuterium content of the c5-CH2O fragment (1.1) is
close to the theoretical value for 100% scrambling (1.2).
Similarly, the deuterium content of the most abundant
C-terminal fragment z9-H2O (2.0) is in good agreement
with the 100% scrambling value (1.8). Extensive posi-
tional randomization among all exchangeable hydro-
gens has thus occurred upon collisional activation of
deprotonated AE133. A similar result was obtained for
protonated AE133 [6, 7]. The occurrence of hydrogen
scrambling for protonated peptides can be rationalized
within the framework of the “mobile proton” model for
peptide fragmentation [1, 35]. In this model, peptide
bond dissociation is initiated by a proton transfer from
a basic site to the less basic back-bone amide nitrogen.
This endothermic reaction is facilitated by the vibra-
tional excitation that results from collisional activa-
tion. The extensive scrambling is caused by reversible
proton/deuteron transfer processes among all N- and
O-bonded hydrogens in the activated peptide ion. An
analogous situation exists in the deprotonated AE133
peptide, where a “mobile deprotonation site” (a term
used in [17]) results in extensive hydrogen scrambling.
The backbone amides are highly involved in the “mo-
bile deprotonation” as evidenced by the intramolecular
migration of amide deuterons from the C-terminal half
of AE133 to its N-terminal residues. Interestingly, the
deprotonation site may also include C-bonded hydro-
gens that are adjacent to a carbonyl group (thereby
yielding an enolate ion). C-deprotonation has thus been
shown to compete with deprotonation of a carboxyl
group under kinetically controlled conditions, as acetic
acid enolate (CH2CO2H) is formed together with ace-
tate ion (CH3CO2
) when acetic acid reacts with OH
Figure 4. Hydrogen scrambling during gas-phase fragmentation of deprotonated selectively labeled
AE133 peptide. MALDI-TOF MS/MS of the selectively labeled KGSGGD-Cha-FsrYLWS (AE133) and
the nonlabeled control. The c5-CH2O is a sensitive probe for the occurrence of amide hydrogen
scrambling because it contains0 deuterons before ion activation. The lower panel shows the isotopic
distribution of the c5-CH2O and z9-H2O in the labeled (lower distribution) and nonlabeled (upper
distribution) peptide.
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and other strong bases in the gas phase [36]. Also,
low-energy CID experiments on smaller deprotonated
peptides containing exclusively H or alkyl side chains
have revealed a limited interchange between C-bonded
and N-bonded hydrogens during the formation of c-
ions [25]. It is, however, not possible from our results to
determine to what extent C-bonded hydrogens have
participated in the scrambling processes. Nevertheless,
our results show that the solution deuteration pattern of
the deprotonated peptide is completely erased upon
collisional activation. It is thus clear that backbone
amides are highly involved in the deprotonation reac-
tions in the activated peptide.
Conclusions
We have used a model peptide with a unique selective
deuterium labeling to investigate the occurrence of
gas-phase hydrogen scrambling upon collisional activa-
tion in negative ion mode. The deuterium content of the
anionic N-terminal fragment ion, c5-CH2O, reveals that
amide deuterons from the C-terminal half have mi-
grated intramolecularly to the N-terminal residues
upon activation. These results clearly demonstrate that
the backbone amides are highly “mobile deprotonation
sites” in a vibrationally excited deprotonated peptide.
Consequently, CID is not an adequate experimental tool
for obtaining site-specific information about deutera-
tion patterns of deprotonated peptides. Fragmentation
by electron detachment dissociation (EDD) may, how-
ever, hold promise as a gas-phase fragmentation
method for this particular purpose [37, 38]. In EDD, the
anionic peptide is irradiated with electrons and back-
bone dissociation occurs with limited vibrational exci-
tation, as the fragment ions mostly retain their labile
post translational modifications [38]. Thus, EDD may be
used for deducing the solution deuteration pattern for
deprotonated peptides, in a manner similar to electron
capture dissociation (ECD) for protonated peptides [39].
Alternatively, MALDI in-source decay of deprotonated
peptides is likely to preserve their solution deuteration
pattern, as fragmentation by this technique occurs with
a very low degree of scrambling for positive ions [40].
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